Find News

Filter articles

Showing 1 to 10 of 3239 results

Cutting back the thickets of Biosimilars

International01-03-2021Alex Baldwin

The Biologics market has changed dramatically since the introduction of the Biologics Price Competition and Innovation Act in 2014 in the US. The act provides a pathway for similar biologics to make it to market safely, cost-effectively, and legally.

BGI secures appeal trial over Illumina DNA verdict

UK25-02-2021Alex Baldwin

Chinese genome sequencing company BGI has been given the go-ahead to appeal an English High Court ruling in an ongoing lawsuit launched by competitor Illumina regarding its DNA sequencing patents.

Five minutes with… Irena Royzman

International25-02-2021Alex Baldwin

Since the formalisation of the new Biologics Price Competition and Innovation Act framework in 2014, there has been a wave of patent infringement litigation, leading to a trend of innovator-versus-biosimilar disputes.

Nevro escalates patent dispute with Boston Scientific

US25-02-2021Muireann Bolger

Medical device maker Nevro has hit competitor Boston Scientific with a lawsuit for allegedly infringing patents that cover a spinal cord stimulation technology.

Fed Circ panel reviews $235m GSK award over ‘skinny’ Teva generic

US25-02-2021Muireann Bolger

A panel of the US Court of Appeals for the Federal Circuit has considered for a second time the $235 million award to GlaxoSmithKline after Teva Pharmaceuticals was found to have infringed its Coreg heart drug.

COVID-19 spurs medical and pharma rise in ‘Top 100 Global Innovators’ report

International23-02-2021Muireann Bolger

Innovation by medical and pharma sectors has increased over the past year in the wake of the pandemic, a new report by IP services company Clarivate has confirmed.

Bayer sues over syringes used in CT scans

International23-02-2021Rory O'Neill

Bayer Healthcare is suing medical devices manufacturer Ecomed Solutions over allegedly patent-infringing syringes.

AbbVie settles longstanding trade secret dispute with Evolus

US23-02-2021Alex Baldwin

AbbVie and its Korean partner Medytox have settled a trade secret dispute with competitor Evolus over the sale of a rival botox competitor drug Jeuveau.

Fed Circuit cancels skin cancer detection patent

US22-02-2021Rory O'Neill

The US Court of Appeals for the Federal Circuit has cancelled claims of a Melanoscan patent covering methods of detecting skin cancer.

Amarin petitions Supreme Court to revive Vascepa patents

US18-02-2021Alex Baldwin

Irish pharmaceutical company Amarin has petitioned the Supreme Court to revive its patents on its heart medication Vascepa.

Showing 1 to 10 of 3239 results